Apellis Pharmaceuticals, Inc. (APLS)

20.96 +0.50 (+2.42%) USD  |  NASDAQ  |  Jan 21, 16:00
20.98 +0.02 (+0.07%) After-Hours: 20:00
More

Apellis Pharmaceuticals Consensus Recommendation

Consensus Recommendation Chart

View Consensus Recommendation for APLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Consensus Recommendation Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Consensus Recommendation Range, Past 5 Years

View Consensus Recommendation Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Consensus Recommendation Benchmarks

View Consensus Recommendation Benchmarks
Start Trial
Amicus Therapeutics, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Ionis Pharmaceuticals, Inc. Upgrade
Fortress Biotech, Inc. Upgrade
Sarepta Therapeutics, Inc. Upgrade